- 专利标题： Use of Ultrarapid Acting Insulin
-
申请号： US16385915申请日： 2019-04-16
-
公开(公告)号： US20190307853A1公开(公告)日： 2019-10-10
- 发明人: Anders Hasager Boss , Richard Petrucci
- 申请人： MannKind Corporation
- 主分类号： A61K38/28
- IPC分类号： A61K38/28 ; A61K9/00 ; A61K31/155
摘要：
Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.
公开/授权文献
- US11013788B2 Use of ultrarapid acting insulin 公开/授权日：2021-05-25
信息查询
IPC分类:
